AzTrials
AzTrials

Adult Spinal DeformityNCT07105189

Feasibility of Wireless Continuous Vital Sign Monitoring and Impact on Patients Undergoing Adult Spinal Surgery in a General Ward

A study testing Wireless monitoring in people with Adult Spinal Deformity and Wireless Continuous Vital Signs Monitoring, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this feasibility study is to explore the use of wireless continuous vital sign monitoring in an orthopaedic setting among orthopaedic nurses and patients undergoing adult spinal deformity surgery. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Wireless monitoring
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteDenmark
Study dates
10 Dec 2025to 31 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Included are adult patients (>=18 years) scheduled for ASD surgery with estimated a >3 day expected post-operative stay. ASD-surgery is defined as a posterior instrumented fusion of at least five spinal levels including instrumentation to the pelvis, caused by a degenerative condition of the spine.
  • Registered nurses and nurses' assistants employed at the orthopedic ward during the study period will be included if they have experience working with wCVSM during the study period. The study includes both sexes, variation of level of education and years of work experience. Included nurses and nurses' assistants should be proficient in the Danish language.

Who cannot join

  • Exclusion criteria are patients who are unable to wear continuous monitoring due to a pacemaker or allergy.
  • Patients who are not proficient in the Danish language will be excluded.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Camilla Hedegaard Larsen contact

+4553651065

camilla.hedegaard.larsen@regionh.dk

Denmark1 site, 1 recruiting
  • Department of Bone and Joint surgery, University hospital, Rigshospitalet, Copenhagen

    Copenhagen, 2100

    Camilla Hedegaard Larsen, +45 35454599, camilla.hedegaard.larsen@regionh.dk

    Recruiting

Other trials in Denmark

About this study

The goal of this feasibility study is to explore the use of wireless continuous vital sign monitoring in an orthopaedic setting among orthopaedic nurses and patients undergoing adult spinal deformity surgery. In addition to the standard care National Early Warning Score the participants in this study will be monitored by CPC12S a wearable sensor that is worn on the chest using electrodes measuring electrocardiography single lead (ECG), Heart rate, respiratory rate, SpO2, blood pressure and temperature.

Main hypotheses:

Read more

The use of wireless continuous vital sign monitoring in daily clinical practice for patients undergoing ASD surgery is feasible in terms of increased acceptability among orthopeadic surgical nurses measured over 12 months with a response rate of at least 80% with an average score of ≥5 at the last measurement in each of the four dimensions of the USE questionnaire: Usefulness, ease of use, ease of learning and satisfaction.

The following parameters will be evaluated:

Primary outcome:

  1. The feasibility in terms of acceptability of the concept of wCVSM among orthopedic surgical ward nurses. Secondary outcomes:
  2. The feasibility in terms of acceptability of the concept of wCVSM in patients undergoing ASD surgery.
  3. The technical fidelity of wCVSM, assessed by data collected of vital signs, display of alerts to staff nurses and response to the alerts.
  4. The frequency of vital sign deviations in patients after ASD surgery using wCVSM compared to NEWS2.
  5. Clinical outcomes of patients undergoing ASD surgery including surgical complications, reinterventions, ICU admissions, unplanned ward transfer, and admissions to another department.
Read the detailed description

Patients undergoing adult spinal deformity surgery (ASD) is associated with high complication rate and long postoperative recovery (Bess et al., 2023). Patients undergoing ASD surgery are particularly susceptible to adverse events such as electrolyte imbalance, cardiac arrhythmia, anemia, hypotension, fever of unknown origin (Karstensen et al., 2016; Solumsmoen et al., 2021). Additionally, patients undergoing ASD surgery is also associated with severe postoperative pain, often requiring high levels of pain medication (Lamperti et al., 2017; Waelkens et al., 2021), there can lead to decreased respiration rate, sedation, and dizziness (Benyamin et al., 2008).Patients undergoing ASD surgery have a readmission percent within 30 days of 11,8 % and a 2-year all-cause mortality of 3% (Bari et al., 2020).

To ensure safety in patients undergoing ASD surgery, nurses must monitor vital signs to assess patients' health condition and act promptly when signs of clinical deterioration become evident. NEWS2 system is used to identify these early signs of clinical deterioration (Smith et al., 2019). The scoring system relies on six simple physiological parameters, including blood pressure, pulse, respiratory rate, peripheral oxygen saturation, temperature, level of consciousness and an associated algorithm (Smith et al., 2019). Since measurements with NEWS2 are intermittent, they often provide a temporary view of the patient's condition, and the system may therefore overlook changes in the patient's condition that occur between measurement (Downey et al., 2017).

Wireless continuous vital sign monitoring (wCVSM) offers an alternative to intermittent measurements. wCVSM systems can be defined as wearable technologies that enable continuous, real-time vital sign monitoring without direct contact between patients and health-care providers. These systems transmit vital sign data to an application on the nurses´ mobile phones, enabling the recognition of clinical deterioration in real time and facilitating a prompt response to patients' needs (Haahr-Raunkjaer et al., 2022; Leenen et al., 2020). To evaluate the feasibility of wCVSM, it is essential to assess its acceptability among orthopaedic surgical nurses and patients undergoing ASD surgery. Their perceptions and willingness to adopt this technology are essential for ensuring its practical integration, consistent use, and long-term sustainability in enhancing clinical outcomes and patient safety.

This study will contribute to our understanding of wCVSM's potential to enhance patient safety, its applicability in clinical practice, and provide necessary considerations when implementing new technological equipment.

In the current study patients undergoing ASD Surgery will, in addition to standard care the National Early Warning Score 2 (NEWS2) be monitored by wireless continuous vital sign monitoring (wCVSM) using the multiparameter ambulatory telemonitoring system CPC12S system and WARD-CSS application postoperatively.

CPC12S is a wearable sensor that is worn on the chest using electrodes measuring electrocardiography single lead (ECG), Heart rate, respiratory rate, SpO2, blood pressure and temperature. The system can also be used to registration of body position and movement, but this will not be used in this study.

Vital signs are updated every 20 seconds and measurements are transmitted via Bluetooth to an Android cell phone that is uploading the data via WIFI to a secured server.

Once every 20 second the vital signs measurements will be transmitted to the CPC12S software system and when to the WARD application displayed on the electronic device Zebra carried by the nurses. The WARD-CSS application is combining innovative technology with evidence-based algorithms and allow earlier and more frequent detection of patient deterioration trough predictive algorithms (https://ward247.com/wp-content/uploads/2024/11/Instructions-for-Use-WARD-CSS-Version-1.3.x-English-US-v6-20241118_185730.pdf.)

The following parameters will be evaluated:

Primary outcome:

  1. The feasibility in terms of acceptability of the concept of wCVSM among orthopedic surgical ward nurses. Secondary outcomes:
  2. The feasibility in terms of acceptability of the concept of wCVSM in patients undergoing ASD surgery.
  3. The technical fidelity of wCVSM, assessed by data collected of vital signs, display of alerts to staff nurses and response to the alerts.
  4. The frequency of vital sign deviations in patients after ASD surgery using wCVSM compared to NEWS2.
  5. Clinical outcomes of patients undergoing ASD surgery including surgical complications, reinterventions, ICU admissions, unplanned ward transfer, and admissions to another department.

Study design This feasibility study is designed as a single-arm prospective clinical cohort.

Nurse acceptability:

Acceptability by nurses will be measured longitudinally. Acceptability by nurses will be measured by the usefulness, satisfaction, and ease of use questionnaire. The questionnaire is translated into Danish guided by internationally accepted guidelines.

All nurses and nurses' assistants employed on the ward (approx. n=50) will receive the (USE) questionnaire by e-mail at T1 baseline, T2 at 6 months, and T3 at 12 months.

Patient acceptability:

Patient acceptability will be measured cross-sectional by the AIM questionnaire and questionnaire based on The theoretical framework of acceptability.

Fidelity:

Fidelity will be measured prospectively and will focus on the functioning of the continuous monitoring system and will be obtained by analysis of the collected data. Outcomes will be total monitoring time, total number of artefacts (if nonvalid measurement is recorded), number of alerts (system and vital sign), and response to alerts will be assessed using the response buttons on the WARD application.

Frequency of deviations in vital signs in patients after ASD surgery using wCVSM compared to NEWS2 will be measured by following:

  1. How many deviations are detected per patient per day with wCVSM.
  2. How many deviations are detected per patient per day with NEWS2
  3. How often does wCVSM detect deviations that do not appear in NEWS2 measurements.

Clinical outcomes include length of stay, surgical complications according to the Clavien Dindo classification, reinterventions, unplanned ward transfer, and unplanned ICU admissions.

Analysis Data analysis will be conducted using descriptive statistics. Continuous data will be calculated for normal distribution by medians and interquartile or means and standard deviations (SD). Every parameter will be checked for normality by the Shapiro-Wilk test and visually by a histogram. The results from the questionnaires will be analyzed and reported as continuous data.

Being tested
Wireless monitoring

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Wireless monitoringDevice

    Patients included in the study will be continuous monitored by CPC12S is a wearable sensor that is worn on the chest using electrodes measuring electrocardiography single lead (ECG), Heart rate, respiratory rate, SpO2, blood pressure and temperature.

    The system calculates the heart rate by analysing R-peaks of QRS-complexes in the raw ECG data.

    Respiratory rate is recorded using impedance pneumography. SpO2 is determined by analysing the photoplethysmogram (PPG) wave. Blood pressure is derived by calculating the pulse transit time (PTT) using R-peaks from the QRS complexes, peaks in the photoplethysmogram (PPG) pulse waves, and timing of the second heart-tone corresponding to the dicrotic notch, measured by a stethoscope in the device.

    Temperature is measured by a thermistor placed in the axilla. Vital signs are updated every 20 seconds and measurements are transmitted via Bluetooth to an Android cell phone that is uploading the data via WIFI to a secured server.

Study groups in NCT07105189
Study groupRoleWhat they receive
Wireless continuous vital sign monitoring in patients undergoing adult spinal deformity surgeryExperimentalParticipants in this arm will receive a wearable wireless continuous vital sign monitoring system (CPC12S), applied after spinal deformity surgery and worn during the initial postoperative period (typically 3-5 days). The device transmits data wirelessly to a mobile application accessed by nursing staff.
Receives: Device: Wireless monitoring

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of acceptability of the concept of wCVSM among orthopedic surgical ward nurses.

    USE questionnaires will be distributed to the nurses taking care of patients undergoing ASD surgery.

    Measured: At 1, 6 and 12 months after post-implementation

Secondary outcomes (4)
  1. Assessment of acceptability of the concept of wCVSM in patients undergoing ASD surgery.

    Patient acceptability will be measured cross-sectional by the AIM questionnaire and questionnaire based on The theoretical framework of acceptability. Questionnaires will be distributed to the patients before discharge

    Measured: up to 7 days

  2. Tecnical fidelity of the functioning of the continuous monitoring system

    Quantify total monitoring time, false positive alerts, false negative alerts and responses to alerts

    Measured: Up to 7 days

  3. Frequency of deviations in vital signs in patients after ASD surgery using wCVSM compared to NEWS2

    The mean deviations detected per patient per day with wCVSM compared to deviations detected per patient per day with routine measurement.

    Measured: Up to 7 days

  4. Assessment of clinical outcomes after ASD surgery

    The mean surgical complications after ASD surgery.

    Measured: Up to 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2025
  2. Study start10 Dec 2025
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07105189
Sponsor's protocol ID
WCVSM-ASD
Status last verified
Jan 2026
First submitted
10 Jan 2025
Last updated
9 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Wireless monitoring in people with Adult Spinal Deformity and Wireless Continuous Vital Signs Monitoring, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Camilla Hedegaard Larsen (+4553651065, camilla.hedegaard.larsen@regionh.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of acceptability of the concept of wCVSM among orthopedic surgical ward nurses. (time frame: At 1, 6 and 12 months after post-implementation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in